Copyright Reports & Markets. All rights reserved.

Covid-19 Impact on Opioids Agonist Drugs Market, Global Research Reports 2020-2021

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Opioids Agonist Drugs Industry
  • 1.7 COVID-19 Impact: Opioids Agonist Drugs Market Trends

    • 2 Global Opioids Agonist Drugs Quarterly Market Size Analysis

    • 2.1 Opioids Agonist Drugs Business Impact Assessment - COVID-19
      • 2.1.1 Global Opioids Agonist Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Opioids Agonist Drugs Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Opioids Agonist Drugs Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Opioids Agonist Drugs Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Opioids Agonist Drugs Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Opioids Agonist Drugs Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Opioids Agonist Drugs Market
    • 3.5 Key Manufacturers Opioids Agonist Drugs Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Opioids Agonist Drugs Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Codeine
      • 1.4.2 Fentanyl
      • 1.4.3 Meperidine
      • 1.4.4 Methadone
      • 1.4.5 Morphine
      • 1.4.6 Hydrocodone
    • 4.2 By Type, Global Opioids Agonist Drugs Market Size, 2019-2021
      • 4.2.1 By Type, Global Opioids Agonist Drugs Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Opioids Agonist Drugs Price, 2020-2021

    5 Impact of Covid-19 on Opioids Agonist Drugs Segments, By Application

    • 5.1 Overview
      • 5.5.1 Pain Management
      • 5.5.2 Cough Treatment
      • 5.5.3 Diarrhea Treatment
    • 5.2 By Application, Global Opioids Agonist Drugs Market Size, 2019-2021
      • 5.2.1 By Application, Global Opioids Agonist Drugs Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Opioids Agonist Drugs Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Purdue Pharma
      • 7.1.1 Purdue Pharma Business Overview
      • 7.1.2 Purdue Pharma Opioids Agonist Drugs Quarterly Production and Revenue, 2020
      • 7.1.3 Purdue Pharma Opioids Agonist Drugs Product Introduction
      • 7.1.4 Purdue Pharma Response to COVID-19 and Related Developments
    • 7.2 Titan pharmaceuticals
      • 7.2.1 Titan pharmaceuticals Business Overview
      • 7.2.2 Titan pharmaceuticals Opioids Agonist Drugs Quarterly Production and Revenue, 2020
      • 7.2.3 Titan pharmaceuticals Opioids Agonist Drugs Product Introduction
      • 7.2.4 Titan pharmaceuticals Response to COVID-19 and Related Developments
    • 7.3 Boehringer Ingelheim
      • 7.3.1 Boehringer Ingelheim Business Overview
      • 7.3.2 Boehringer Ingelheim Opioids Agonist Drugs Quarterly Production and Revenue, 2020
      • 7.3.3 Boehringer Ingelheim Opioids Agonist Drugs Product Introduction
      • 7.3.4 Boehringer Ingelheim Response to COVID-19 and Related Developments
    • 7.4 Janssen Pharmaceuticals, Inc
      • 7.4.1 Janssen Pharmaceuticals, Inc Business Overview
      • 7.4.2 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Quarterly Production and Revenue, 2020
      • 7.4.3 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product Introduction
      • 7.4.4 Janssen Pharmaceuticals, Inc Response to COVID-19 and Related Developments
    • 7.5 Sanofi
      • 7.5.1 Sanofi Business Overview
      • 7.5.2 Sanofi Opioids Agonist Drugs Quarterly Production and Revenue, 2020
      • 7.5.3 Sanofi Opioids Agonist Drugs Product Introduction
      • 7.5.4 Sanofi Response to COVID-19 and Related Developments
    • 7.6 Sun Pharmaceuticals
      • 7.6.1 Sun Pharmaceuticals Business Overview
      • 7.6.2 Sun Pharmaceuticals Opioids Agonist Drugs Quarterly Production and Revenue, 2020
      • 7.6.3 Sun Pharmaceuticals Opioids Agonist Drugs Product Introduction
      • 7.6.4 Sun Pharmaceuticals Response to COVID-19 and Related Developments
    • 7.7 Mallinckrodt Pharmaceuticals
      • 7.7.1 Mallinckrodt Pharmaceuticals Business Overview
      • 7.7.2 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Quarterly Production and Revenue, 2020
      • 7.7.3 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product Introduction
      • 7.7.4 Mallinckrodt Pharmaceuticals Response to COVID-19 and Related Developments
    • 7.8 Egalet Corporation
      • 7.8.1 Egalet Corporation Business Overview
      • 7.8.2 Egalet Corporation Opioids Agonist Drugs Quarterly Production and Revenue, 2020
      • 7.8.3 Egalet Corporation Opioids Agonist Drugs Product Introduction
      • 7.8.4 Egalet Corporation Response to COVID-19 and Related Developments
    • 7.9 Endo Pharmaceuticals Inc.
      • 7.9.1 Endo Pharmaceuticals Inc. Business Overview
      • 7.9.2 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Quarterly Production and Revenue, 2020
      • 7.9.3 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product Introduction
      • 7.9.4 Endo Pharmaceuticals Inc. Response to COVID-19 and Related Developments
    • 7.10 Allergan, Plc
      • 7.10.1 Allergan, Plc Business Overview
      • 7.10.2 Allergan, Plc Opioids Agonist Drugs Quarterly Production and Revenue, 2020
      • 7.10.3 Allergan, Plc Opioids Agonist Drugs Product Introduction
      • 7.10.4 Allergan, Plc Response to COVID-19 and Related Developments
    • 7.11 Pfizer Inc
      • 7.11.1 Pfizer Inc Business Overview
      • 7.11.2 Pfizer Inc Opioids Agonist Drugs Quarterly Production and Revenue, 2020
      • 7.11.3 Pfizer Inc Opioids Agonist Drugs Product Introduction
      • 7.11.4 Pfizer Inc Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Opioids Agonist Drugs Supply Chain Analysis
      • 8.1.1 Opioids Agonist Drugs Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Opioids Agonist Drugs Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Opioids Agonist Drugs Distribution Channels
      • 8.2.2 Covid-19 Impact on Opioids Agonist Drugs Distribution Channels
      • 8.2.3 Opioids Agonist Drugs Distributors
    • 8.3 Opioids Agonist Drugs Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Opioids Agonist Drugs, including the following market information:
      Global Opioids Agonist Drugs Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Opioids Agonist Drugs Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Opioids Agonist Drugs Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Opioids Agonist Drugs Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

      Key market players
      Major competitors identified in this market include Purdue Pharma, Titan pharmaceuticals, Boehringer Ingelheim, Janssen Pharmaceuticals, Inc, Sanofi, Sun Pharmaceuticals, Mallinckrodt Pharmaceuticals, Egalet Corporation, Endo Pharmaceuticals Inc., Allergan, Plc, Pfizer Inc, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Codeine
      Fentanyl
      Meperidine
      Methadone
      Morphine
      Hydrocodone

      Based on the Application:
      Pain Management
      Cough Treatment
      Diarrhea Treatment

      Buy now